Viewing Study NCT04691453



Ignite Creation Date: 2024-05-06 @ 3:37 PM
Last Modification Date: 2024-10-26 @ 1:53 PM
Study NCT ID: NCT04691453
Status: RECRUITING
Last Update Posted: 2020-12-31
First Post: 2020-10-20

Brief Title: QM-B and QM-C Hysterectomy for Early Cervical Cancer
Sponsor: Southern Medical University China
Organization: Southern Medical University China

Study Overview

Official Title: Randomized Clinical Trial Comparing the Oncology Outcome and Safety of QM-B and QM-C Hysterectomy for Early Cervical Cancer
Status: RECRUITING
Status Verified Date: 2020-12
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: QMBCHECC
Brief Summary: The goal of this clinical research study is to compare the long-term outcomes and safety of Querleu-Morrow-BQM-B and Querleu-Morrow-CQM-C hysterectomy for early cervical cancer In this study the surgical approach for QM-B and QM-C hysterectomy will be abdominal
Detailed Description: Primary Objective

To compare 5-year overall survival and 5-year disease-free survival amongst patients who undergo a QM-B hysterectomy versus those who undergo a QM-C hysterectomy for early stage cervical cancer

Secondary Objectives

Compare operation time between arms Compare blood loss between arms Compare blood transfusion between arms Compare intraoperative complications between arms Compare postoperative complications between arms Compare quality of lifes between arms

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None